Takeda Triumphs In Suits To Block Generic Dexilant
Takeda Pharmaceutical Co. Ltd. on Friday scored victories in three of its patent infringement suits in California federal court against drugmakers looking to sell a generic version of its acid reflux...To view the full article, register now.
Already a subscriber? Click here to view full article